By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Monday, December 20th. Please refresh for updates.
-
Moderna (NASDAQ:MRNA) stock rose 7.7% after the drugmaker announced that a third dose of its Covid vaccine provides significant protection against the Omicron variant. It will also continue to develop an Omicron-specific booster candidate.
- Novavax (NASDAQ:NVAX) stock rose 11.6% after the EU's medicines regulator cleared its Covid-19 vaccine for use in Europe. The company expects to start deliveries to the EU in the first quarter of next year.
-
Exxon Mobil (NYSE:XOM) stock fell 1.8%, Marathon Oil (NYSE:MRO) stock fell 3.4% and Imperial Oil (NYSE:IMO) stock fell 1.9% after UBS announced it has excluded the "unresponsive" energy companies from its climate-aware range of funds.
-
United Airlines (NASDAQ:UAL) stock fell 3.1%, Delta Air Lines (NYSE:DAL) stock fell 3% and American Airlines (NASDAQ:AAL) stock fell 2.8% as worries over travel restrictions weighed on the sector. Royal Caribbean (NYSE:RCL) stock fell 3.4% and Carnival (NYSE:CCL) (NYSE:CUK) stock dropped 3.1%.
-
Tesla (NASDAQ:TSLA) stock fell 2.1%, Apple (NASDAQ:AAPL) stock dropped 1.9%, Microsoft (NASDAQ:MSFT) stock fell 1.4% and Meta Platforms (NASDAQ:FB) stock fell 1.6% as the mega-cap growth stocks extended their falls from the previous session.
-
AT&T (NYSE:T) stock rose 1.5% after Barclays upgraded its investment stance on the telecom giant to ‘overweight’ from ‘equal weight’, saying now is time to buy the long struggling company.
-
Novo Nordisk (CSE:NOVOb) (NYSE:NVO) stock fell 4.4% after the company warned of a hit to the availability of a key obesity drug in the U.S. due to issues at a contract manufacturer.
-
Sunrun (NASDAQ:RUN) stock fell 8.8% after KeyBanc downgraded its stance on the solar power company to 'sector weight' from 'overweight' following proposals in California that would reduce incentives to buy the company’s products.